Lately, a top pharmaceutical giant launched the famous biosimilar bevacizumab as Abevmy nowadays pharmaceutical hub, India. The drug remains approved for every indication relating for that innovator molecule. It offers metastatic colorectal, ovarian, kidney and cervical cancer, glioblastoma and non-small cell lunch carcinoma. There is a drug in 100 mg and 400mg packs. It becomes […]